FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

Janssen-Cilag, S.A.709 enrolled

Overview

The purpose of this study is to establish the relationship between performance of patients with schizophrenia and relationship with perceived quality of sleep. The secondary objectives are: to establish the prevalence of schizophrenic patients reporting sleep disturbances; to assess the potential epidemiological risk factors associated with the perceived impairment of quality of sleep; to establish the relationship between the clinical condition and the quality of sleep perceived; to assess the performance level of patients.

This is a multicenter, cross-sectional, epidemiological study in the daily clinical practice on the relationship between personal and social functionality and quality of sleep perceived in outpatients with schizophrenia. It is proposed to perform a simple screening for detecting schizophrenic patients reporting sleep disturbances. These patients will be assessed in a single visit and will be administered a number of quality of life and functional assessment scales. N/A

Study Type

OBSERVATIONAL

Enrollment

709

Conditions

Schizophrenia

Interventions

Functioning assessmentOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient diagnosed of schizophrenia * reporting sleep disturbances at the time of the visit or patient not reporting sleep disturbances at the time of the visit * who are on stable antipsychotic therapy for at least 6 months prior to inclusion in the study * (or guardian/ legal representative) consenting to participate in the study by signing the written informed consent. Exclusion Criteria: * Patient who, in the investigator's opinion, fails to keep an adequate cognitive ability to continue the study and complete the questionnaires * who has any type of severe sleep disturbances related to disorders of the patient other than schizophrenia (e.g., nightmares, nocturnal fears, restless leg syndrome) * or included in another clinical study or trial that can interfere with the normal control of the disease.